MARKET

AMRX

AMRX

Amneal Pharmaceuticals Inc
NASDAQ
7.97
-0.27
-3.28%
After Hours: 7.97 0 0.00% 19:54 07/18 EDT
OPEN
8.30
PREV CLOSE
8.24
HIGH
8.30
LOW
7.97
VOLUME
1.17M
TURNOVER
--
52 WEEK HIGH
9.48
52 WEEK LOW
6.50
MARKET CAP
2.50B
P/E (TTM)
-189.7619
1D
5D
1M
3M
1Y
5Y
1D
Knight Therapeutics announces CREXONT NDS accepted for Health Canada review
TipRanks · 2d ago
Knight Therapeutics Inc. Announces Health Canada's Acceptance of New Drug Submission for CREXONT® Extended-Release Capsules
Reuters · 2d ago
KNIGHT THERAPEUTICS ANNOUNCES FILING OF NEW DRUG SUBMISSION FOR CREXONT® (CARBIDOPA AND LEVODOPA) EXTENDED-RELEASE CAPSULES IN CANADA
Reuters · 2d ago
Amneal Pharmaceuticals (AMRX) Gets a Buy from Goldman Sachs
TipRanks · 4d ago
Weekly Report: what happened at AMRX last week (0707-0711)?
Weekly Report · 6d ago
Amneal Pharmaceuticals Inc. to Release Second Quarter 2025 Financial Results
Reuters · 07/09 12:00
Press Release: Amneal to Report Second Quarter 2025 Results on August 5, 2025
Dow Jones · 07/09 12:00
Jazz Pharmaceuticals: I See Big Potential In This Stock As An Investor
Seeking Alpha · 07/07 13:30
More
About AMRX
Amneal Pharmaceuticals, Inc. is a global pharmaceutical company, which develops, manufactures, markets and distributes a portfolio of essential medicines. Its Affordable Medicines segment includes a portfolio of over 280 product families covering a range of dosage forms and delivery systems, including both immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmic, films, transdermal patches and topicals. Its Specialty segment is engaged in the development, promotion, sale and distribution of branded pharmaceutical products, with a focus on products addressing central nervous system disorders, including Parkinson’s disease and endocrine disorders. Its AvKARE segment provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies, predominantly focused on the U.S. Department of Defense and the U.S. Department of Veterans Affairs.

Webull offers Amneal Pharmaceuticals Inc stock information, including NASDAQ: AMRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AMRX stock methods without spending real money on the virtual paper trading platform.